Sycamore House, Stevenage
Having historically been involved in strategic discussions and instructions with a variety of stakeholders in Stevenage for several years, including GSK, the Stevenage Biosciences Catalyst and the Cell and Gene Therapy Manufacturing Catapult, it was evident that expanding occupiers in the ecosystem had pent up demand for space.
To unlock this, we arranged a complex sale and leaseback purchase of Sycamore House from GSK by our client, Kadans Science Partner, to provide 70,000 sq ft of commercial laboratory and office space to occupiers after a comprehensive refurbishment of the building which was an existing warehouse, alongside an additional 30,000 sq ft of space which was retained by GSK.
We advised on the purchase of the asset and subsequently negotiated terms with a number of cell and gene therapy occupiers over the course of the planning and design phase resulting in the building being 100% let prior to completion.
